首页> 美国卫生研究院文献>International Journal of Molecular Sciences >Role of Anesthetics and Their Adjuvants in Neurovascular Protection in Secondary Brain Injury after Aneurysmal Subarachnoid Hemorrhage
【2h】

Role of Anesthetics and Their Adjuvants in Neurovascular Protection in Secondary Brain Injury after Aneurysmal Subarachnoid Hemorrhage

机译:麻醉剂及其佐剂在动脉瘤蛛网膜下腔出血后次生脑损伤中的神经血管保护中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Aneurysmal rupture accounts for the majority of subarachnoid hemorrhage and is responsible for most cerebrovascular deaths with high mortality and morbidity. Initial hemorrhage severity and secondary brain injury due to early brain injury and delayed cerebral ischemia are the major determinants of outcomes after aneurysmal subarachnoid hemorrhage. Several therapies have been explored to prevent these secondary brain injury processes after aneurysmal subarachnoid hemorrhage with limited clinical success. Experimental and clinical studies have shown a neuroprotective role of certain anesthetics in cerebrovascular disorders including aneurysmal subarachnoid hemorrhage. The vast majority of aneurysmal subarachnoid hemorrhage patients require general anesthesia for surgical or endovascular repair of their aneurysm. Given the potential impact certain anesthetics have on secondary brain injury after SAH, appropriate selection of anesthetics may prove impactful on overall outcome of these patients. This narrative review focuses on the available evidence of anesthetics and their adjuvants in neurovascular protection in aneurysmal subarachnoid hemorrhage and discusses current impact on clinical care and future investigative directions.
机译:动脉瘤破裂占大多数蛛网膜下腔出血,并负责大多数脑血管死亡,死亡率高和发病率。由于早期脑损伤和延迟脑缺血引起的初始出血严重程度和继发性脑损伤是动脉瘤性蛛网膜下腔出血后结果的主要决定因素。已经探索了几种疗法,以防止这些继发性脑损伤过程在动脉瘤蛛网膜下腔出血后,临床成功有限。实验和临床研究表明了某些麻醉剂在脑血管障碍中的神经保护作用,包括动脉瘤蛛网膜瘤出血。绝大多数动脉瘤蛛网膜下腔出血患者需要全身麻醉,用于其动脉瘤的外科或血管内修复。 Given the potential impact certain anesthetics have on secondary brain injury after SAH, appropriate selection of anesthetics may prove impactful on overall outcome of these patients.这种叙事综述侧重于动脉瘤蛛网膜瘤出血中的麻醉剂和佐剂中的可用证据,并探讨了目前对临床护理和未来调查方向的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号